Silodosin Prices — US Pharmacy Cost vs Canada — Save Up to 90% in the US

Our most recent US pharmacy data shows a low of roughly $21.20 for Silodosin with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Yes — Cost Plus Drugs lists Silodosin at roughly $0.088 per unit, a published price with no membership card or coupon involved. See the three-price comparison above for how that stacks up against discount-card pharmacies.

We found Canadian pricing for Silodosin starting near $0.870 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. In this case, our data shows the US price is actually the lower of the two once a program like Cost Plus Drugs is factored in — the assumption that Canada is always cheaper doesn't hold for every drug.

The final cost of Silodosin with insurance depends entirely on your specific plan's formulary and pharmacy benefits. Your copay could vary from a few dollars to a higher tier cost. To get accurate pricing, you should contact your insurance provider directly. If your plan does not cover Silodosin or imposes a high copay, it's worth exploring other cost-saving options. These can include pharmacy discount programs, manufacturer patient assistance programs, or checking prices with different pharmacies, which may offer lower cash prices. Patients with Medicare or Medicaid can also investigate whether these programs provide additional savings options if coverage is limited.

Silodosin is the generic version of the brand-name drug Rapaflo. Both contain the same active ingredient and provide the same therapeutic effect. Choosing the generic Silodosin is a common way to achieve significant cost savings, as generic medications are typically priced much lower than their brand-name equivalents.